Patient perspectives of prosthetic heart valve choice and anticoagulation in patients with rheumatic heart disease: a semi-quantitative study - Report - MDSpire
Advertisement
Patient perspectives of prosthetic heart valve choice and anticoagulation in patients with rheumatic heart disease: a semi-quantitative study
Clinical Report: Patient Insights on Prosthetic Heart Valve Selection in RHD
Overview
This study explores the factors influencing prosthetic heart valve selection among patients with rheumatic heart disease (RHD) and their knowledge of anticoagulation management. Key findings indicate a preference for bioprosthetic valves among younger patients and highlight gaps in post-operative follow-up care.
Background
Rheumatic heart disease (RHD) significantly impacts cardiovascular health, particularly in lower socioeconomic populations. Surgical intervention, primarily valve replacement, is crucial for managing RHD, yet patient outcomes can be suboptimal due to challenges in anticoagulation management. Understanding patient preferences and experiences is essential for improving decision-making and care pathways.
Data Highlights
{'bioprosthetic_valves_implanted': '133 (61%) of 218 patients'}
Key Findings
Majority of patients (61%) received bioprosthetic valves.
Younger and older patients preferred bioprosthetic valves, while middle-aged patients favored mechanical valves.
Surgeons and cardiologists were the primary sources of information influencing valve choice.
Significant gaps in follow-up care were noted, with 34% not seeing a cardiologist post-operatively.
Patient education on valve durability and anticoagulation management is lacking.
Clinical Implications
Healthcare professionals should prioritize patient education regarding valve options and anticoagulation management to enhance decision-making. Establishing robust follow-up pathways is critical to ensure patients receive necessary post-operative care.
Conclusion
The findings underscore the need for improved educational resources and follow-up strategies to support RHD patients in their valve selection and anticoagulation management.
